The significance of PP2A methylation is further highlighted through the discovery that reduced PP2A methylation, reduced LCMT-1, and elevated PME-1 expression have been found in postmortem brains of PD and AD patients (Park et al., 2016, 2017). This evidence concerns the gene PPME1 and Parkinson disease.